Indian Pharma Industry witnesses new trends introduced by Schott Kaisha

Schott Kaisha successfully concluded its 5-city roadshow, bringing together industry experts, R & D specialists, business and sales leaders for discussions on the latest technological advancements and best practices that lead to drug safety. Held over 2 weeks, the events gave participants a clear understanding on the importance of conversion process in tubular glass manufacturing, and showcased Schott Kaisha's upcoming product portfolio, tailor-made design and development capabilities.

Rishad Dadachanji, Director, Schott Kaisha shared, "the Indian packaging industry is undergoing rapid growth and we have always been committed to address the demands and challenges of our customers. Hence, we always work together with our partners to deliver better integrated lines of solutions and services. We are extremely happy with the response at the roadshow. This has helped us further strengthen our position in the industry as a catalyst of innovation and technology. As a key takeaway, we have decided to work even closer with our stakeholders and meet their demands by investing in yet another manufacturing unit in Umarsadi, Gujarat, as well as plan to set up an entirely new plant in northern India."

With fresh investments in new sites in Gujarat and North India, expansion and upgradation of existing plants in Daman and Jambusar, Schott Kaisha’s financial commitment will further increase by up to INR 500 crores between 2018 and 2020. The increased capacity will cater to the growing demand of ampoules, vials, syringes, cartridges and sterile portfolio. Through this increased production capacity, the company is focussing on catering to the domestic market first, with a current supply to export ratio of 75:25.